Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Maxcyte, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 99 | 2 | 104 | +7 |
| Shares | 68.6M | 136.7K | 68.3M | −185.8K (−0.3%) |
| Value | $479.8M | $955.0K | $322.7M | −$156.1M (−32.6%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Maxcyte, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lazard Asset Management LLC | 466,601 | $2.21M | 0.00% |
| Marshall Wace, LLP | 257,068 | $1.22M | 0.00% |
| M&T Bank Corp | 105,626 | $500.0K | 0.00% |
| Bridgeway Capital Management, LLC | 101,200 | $479.0K | 0.01% |
| SEI Investments Co | 89,280 | $422.0K | 0.00% |
| Ergoteles LLC | 64,500 | $305.0K | 0.01% |
| Man Group plc | – | $189.0K | 0.00% |
| DekaBank Deutsche Girozentrale | 38,500 | $186.0K | 0.00% |
| Voya Investment Management LLC | 34,398 | $163.0K | 0.00% |
| SG Americas Securities, LLC | 33,768 | $160.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 30,938 | $146.0K | 0.00% |
| Squarepoint Ops LLC | 24,000 | $114.0K | 0.00% |
| Cantor Fitzgerald, L. P. | 25,169 | $113.0K | 0.00% |
| State of Wisconsin Investment Board | 17,140 | $77.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 16,006 | $76.0K | 0.00% |
| PDT Partners, LLC | 16,080 | $76.0K | 0.01% |
| Alliancebernstein L.P. | 11,600 | $55.0K | 0.00% |
| Quantbot Technologies LP | 5,782 | $27.0K | 0.00% |
| State of Wyoming | 4,071 | $19.0K | 0.01% |
| Total Clarity Wealth Management, Inc. | 1,518 | $7.00K | 0.00% |
| Exane Derivatives | 502 | $2.33K | 0.00% |
| CWM, LLC | 33 | $0 | 0.00% |
Sold out (15)
Institutions that held Maxcyte, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| D1 Capital Partners L.P.SuperinvestorD1 Capital Partners | 3,510,000 | $24.5M |
| Nicholas Investment Partners, LP | 776,963 | $5.43M |
| Neuberger Berman Group LLC | 151,706 | $1.06M |
| Ikarian Capital, LLC | 137,958 | $964.0K |
| Cna Financial Corp | 47,974 | $335.0K |
| TD Asset Management Inc | 46,942 | $332.0K |
| D. E. Shaw & Co., Inc. | 45,109 | $315.0K |
| Price T Rowe Associates Inc | 37,018 | $259.0K |
| Must Asset Management Inc. | 27,027 | $188.0K |
| Principal Financial Group Inc | 13,753 | $96.0K |
| Boothbay Fund Management, LLC | 13,143 | $92.0K |
| Nkcfo LLC | 13,000 | $91.0K |
| ExodusPoint Capital Management, LP | 12,261 | $86.0K |
| Ellevest, Inc. | 19 | $0 |
| Bank of Montreal | 32,025 | – |
Not filed for Q2 2022 yet (2)
Institutions that held Maxcyte, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 122,765 | $858.0K |
| Amalgamated Financial Corp. | 13,922 | $97.0K |